BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22724225)

  • 1. [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-aCS) study].
    Takeuchi T; Ota H; Hasebe N
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():336-40. PubMed ID: 22724225
    [No Abstract]   [Full Text] [Related]  

  • 2. Qualitative plaque stabilization but not quantitative plaque regression.
    Nishigaki K
    Circ J; 2012; 76(4):809-11. PubMed ID: 22451448
    [No Abstract]   [Full Text] [Related]  

  • 3. Noninferiority of pitavastatin in intravascular ultrasound findings.
    Kaneda H; Ma J; Morita T
    J Am Coll Cardiol; 2010 Jan; 55(3):262-3; author reply 263. PubMed ID: 20117416
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between circulating matrix metalloproteinase levels and coronary plaque regression after acute coronary syndrome--subanalysis of the JAPAN-ACS study.
    Ogita M; Miyauchi K; Morimoto T; Daida H; Kimura T; Hiro T; Nakagawa Y; Yamagishi M; Ozaki Y; Matsuzaki M
    Atherosclerosis; 2013 Jan; 226(1):275-80. PubMed ID: 23159100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study.
    Miyauchi K; Daida H; Morimoto T; Hiro T; Kimura T; Nakagawa Y; Yamagishi M; Ozaki Y; Kadota K; Kimura K; Hirayama A; Kimura K; Hasegawa Y; Uchiyama S; Matsuzaki M;
    Circ J; 2012; 76(4):825-32. PubMed ID: 22451449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial).
    Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    Circ J; 2010 Jun; 74(6):1165-74. PubMed ID: 20467151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
    Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: subgroup analysis of JAPAN-ACS study.
    Ohashi T; Shibata R; Morimoto T; Kanashiro M; Ishii H; Ichimiya S; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura T; Daida H; Murohara T; Matsuzaki M
    Atherosclerosis; 2010 Sep; 212(1):237-42. PubMed ID: 20684825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study.
    Arai H; Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    J Atheroscler Thromb; 2010 Oct; 17(10):1096-107. PubMed ID: 20675955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustering of metabolic syndrome components attenuates coronary plaque regression during intensive statin therapy in patients with acute coronary syndrome: the JAPAN-ACS subanalysis study.
    Takashima H; Ozaki Y; Morimoto T; Kimura T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Daida H; Mizuno T; Asai K; Kuroda Y; Kosaka T; Kuhara Y; Kurita A; Maeda K; Amano T; Matsuzaki M;
    Circ J; 2012; 76(12):2840-7. PubMed ID: 22972364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS): rationale and design.
    Miyauchi K; Kimura T; Morimoto T; Nakagawa Y; Yamagishi M; Ozaki Y; Hiro T; Daida H; Matsuzaki M
    Circ J; 2006 Dec; 70(12):1624-8. PubMed ID: 17127811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitavastatin: an overview.
    Saito Y
    Atheroscler Suppl; 2011 Nov; 12(3):271-6. PubMed ID: 22152281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study).
    Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    J Am Coll Cardiol; 2009 Jul; 54(4):293-302. PubMed ID: 19608026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study].
    Miyauchi K
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():321-30. PubMed ID: 22724223
    [No Abstract]   [Full Text] [Related]  

  • 15. Who benefits from statins? Patient or focal plaque?
    Fujii K; Masuyama T
    Circ J; 2012; 76(12):2744-5. PubMed ID: 23117744
    [No Abstract]   [Full Text] [Related]  

  • 16. [JAPAN-ACS (Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome)].
    Dohi T; Daida H
    Nihon Rinsho; 2016 Jun; 74 Suppl 4 Pt 1():697-702. PubMed ID: 27534254
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design.
    Lablanche JM; Danchin N; Farnier M; Tedgui A; Vicaut E; Alonso J; Crean P; Leone A; Morais J; Santini M; Licour M; Farah M; Tardif JC
    Arch Cardiovasc Dis; 2008 Jun; 101(6):399-406. PubMed ID: 18809153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dramatic reductions in plaque volumes on maximum statin therapy.
    Cardiovasc J Afr; 2011; 22(6):344-5. PubMed ID: 22159326
    [No Abstract]   [Full Text] [Related]  

  • 19. New evidence on pitavastatin: efficacy and safety in clinical studies.
    Teramoto T; Shimano H; Yokote K; Urashima M
    Expert Opin Pharmacother; 2010 Apr; 11(5):817-28. PubMed ID: 20201733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin loading for acute coronary syndromes.
    Nusca A; Melfi R; Patti G; Di Sciascio G
    Curr Opin Cardiol; 2010 Jul; 25(4):373-8. PubMed ID: 20520540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.